June 2010

Court defends Astra's Crestor patent ()
JACC: Performance measure compliance rates vary in cardiac outpatients ()
ACR balks at FDA control of CT; promotes its model ()
ADA: Diabetes doubles risk of heart attack, stroke ()
ACC/AHA elucidate FDA boxed warning on Plavix for practices ()
Sanofi, Metabolex ink diabetes drug deal worth up to $375M ()
CMS proposes an additional 6.1% cut in Medicare payments ()
HIMSS: RFID still mostly used for equipment tracking ()
ADA: Byetta trumps Lantus in glucose control for diabetics ()
AJC: Younger men with acute MI fare better than women for in-hospital mortality ()
ADA: Dapagliflozin+metformin can improve glucose control for diabetics ()
Spectranetics settles class action suits with shareholders for $8.5M ()
Spectranetics to launch trial for endo in-stent restonsis ()
ACGME recommends a reduction in resident duty hours ()
Actavis taps former Ratiopharm chief as new CEO ()
Study: Exercise alone equal to creatine add-on during cardiac rehab ()
Ortho-McNeil inks two deals to develop diabetes drugs ()
Novo Nordisk re-initiates trials for Victoza ()
Circ: Nitinol stents trump balloon angio for endo arteries ()
New Techniques, Technologies Offer Lower Dose Cardiac CT ()
E-prescribing: Benefits & Drawbacks of Digitalized Health IT Systems ()
N.J. health orgs partner to reduce HF readmissions ()
ACC Corner: Meeting the Online Needs of the Cardiovascular Community ()
IVUS: Becoming a Cath Lab Staple ()
Lilly, Kowa release new statin in U.S. ()
First Word: Game-Changing Technologies Startle & Shine ()
The Back Page: Trending: Conventional EP Device Use Decreases ()
Senate attempts another SGR fix; 21% cut is now in effect ()
AHA statement: Thoracic aortic disease treatments need more review ()
JACC: Warfarin genotyping can reduce hospitalization rates by 30% ()
Lancet: 10 factors account for 90% of stroke risk ()
SVS: Academic providers shouldnt be exempt from transparency rules ()
Esperion, Cleveland Clinic to research new HDL therapies ()
FDA launches website for adverse events with drugs ()
Feature: Experts clash on ARBs potential link to cancer ()
Executive shakeup continues at Cardiva ()
Cochrane: Benefits of oxygen therapy during MI unclear ()
Q&A: Chicago Alliance has data to share ()
Halamka: Open standards are 'key to interoperability' ()
SVS: Post-op MI didnt decrease despite beta blocker usage increase ()
BMS, Pfizer halt apixaban trial due to promising findings ()
Onsite, dispatched or no AED: Differences in costs, survival ()
Experience pays in accuracy of pediatric pulse in cardiac arrest ()
Radiology: CTA can be more appropriately targeted for PE diagnosis ()
Placement and use of AEDs in communities double survival ()
Tennessee provider to buy struggling Ohio health system for $70M ()
SVS: Minimizing treatment time for CEA improves neurological outcomes ()
SVS: Conflicts of interest reporting might actually be more opaque ()
SVS: Statin use prior to CAS can reduce rates of death, stroke ()
FDA investigates risk of cardiac-related deaths with Benicar in diabetics ()
Stroke: Patients who present in 'golden hour' still don't reach proper DTN times ()
Expert roundtable discuss economics of FFR ()
Forest inks diabetes deal that could cost up to $1.1B ()
Consensus doc questions preventive use of aspirin for CV events in diabetics ()
SIIM: Vital updates Vitrea Enterprise Suite ()
Medtronic updates continuous glucose monitoring system ()
St. Jude, two providers settle whistleblower kickback case for $4M ()
ATS Feature: At-home sleep testing equal to in-lab in treatment results ()
AccessClosure shuffles execs ()
Defibtech issues Class 1 recall of 5,418 AED battery packs ()
JAMA: Vascular closure device+bivalirudin stops bleeding, not used uniformly ()
Survey: Economy is adversely affecting IT budgets, personnel ()
Liang becomes new CEO, prez at Medrad ()
Lancet: Avandia/Glucophage combo may be beneficial for diabetes prevention ()
Radiology: Polyp size is critical biomarker for CTC screening, diagnosis ()
CSC: Costs for stroke patients soak up $2.5B per year in Canada ()
JNM: Non-laxative PET/CTC might be particularly beneficial for elderly ()
Medtronic discloses nearly $16M in doc payments for Q1 ()
JAMA Feature: Treatment time, more than strategy, important for STEMIs ()
Medicare benficiaries in donut hole could save 50% on drugs in 2011 ()
Hansen appoints Barclay as new CEO ()
Kansas City CV practice partners with St. Luke's ()
AIM: Group medical clinics improve blood pressure compared with conventional care ()
HRJ: Continuing warfain before device implantation reduces complications ()
Review: Healthcare leaders must simplify administrative structures ()
AHA: Community hospitals may outperform academic centers for EP care ()
HFC: CUPID shows love for genetic treatment of HF ()
Covidien expands vascular platform with $2.6B purchase of ev3 ()
Pfizer halts heart failure trial early because Inspra reaches endpoint ()